Martin Meglasson
2015 - Bellerophon Therapeutics
In 2015, Martin Meglasson earned a total compensation of $868.8K as former Chief Scientific Officer at Bellerophon Therapeutics, a 33% increase compared to previous year.
Compensation breakdown
| Bonus | $106,612 |
|---|---|
| Option Awards | $17,097 |
| Salary | $279,230 |
| Other | $465,842 |
| Total | $868,782 |
Meglasson received $465.8K in other compensation, accounting for 54% of the total pay in 2015.
Meglasson also received $106.6K in bonus, $17.1K in option awards and $279.2K in salary.
Rankings
In 2015, Martin Meglasson's compensation ranked 8,608th out of 13,638 executives tracked by ExecPay. In other words, Meglasson earned more than 36.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,608 out of 13,638 | 37th |
Division Manufacturing | 3,287 out of 5,187 | 37th |
Major group Chemicals And Allied Products | 1,195 out of 1,857 | 36th |
Industry group Drugs | 971 out of 1,531 | 37th |
Industry Pharmaceutical Preparations | 759 out of 1,179 | 36th |
Source: SEC filing on April 27, 2016.
Meglasson's colleagues
We found five more compensation records of executives who worked with Martin Meglasson at Bellerophon Therapeutics in 2015.
2015
Jonathan Peacock
Bellerophon Therapeutics
Chief Executive Officer
2015
Deborah Quinn
Bellerophon Therapeutics
Chief Medical Officer
2015
Reinilde Heyrman
Bellerophon Therapeutics
former Chief Clinical Development Officer
2015
Martin Dekker
Bellerophon Therapeutics
Vice President of Device Engineering and Manufacturing
2015
Peter Fernandes
Bellerophon Therapeutics